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Original article
Dual hypothermic oxygenated machine perfusion in liver
transplants donated after circulatory death
R. van Rijn1,2, N. Karimian1,2, A. P. M. Matton1,2, L. C. Burlage1,2, A. C. Westerkamp1,2,
A. P. van den Berg3, R. H. J. de Kleine1, M. T. de Boer1, T. Lisman1 and R. J. Porte1
1Section of Hepatobiliary Surgery and Liver Transplantation, and 2Surgical Research Laboratory, Department of Surgery and 3Department of
Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
Correspondence to: Dr R. J. Porte, Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University Medical Centre
Groningen, PO Box 30.001, 9700RB Groningen, The Netherlands (e-mail: r.j.porte@umcg.nl)
Background: Experimental studies have suggested that end-ischaemic dual hypothermic oxygenated
machine perfusion (DHOPE) may restore hepatocellular energy status and reduce reperfusion injury
in donation after circulatory death (DCD) liver grafts. The aim of this prospective case–control study
was to assess the safety and feasibility of DHOPE in DCD liver transplantation.
Methods: In consecutive DCD liver transplantations, liver grafts were treated with end-ischaemic
DHOPE. Outcome was compared with that in a control group of DCD liver transplantations without
DHOPE, matched for donor age, donor warm ischaemia time, and recipient Model for End-stage Liver
Disease (MELD) score. All patients were followed for 1 year.
Results: Ten transplantations involving liver grafts treated with DHOPE were compared with 20 control
procedures. There were no technical problems. All 6-month and 1-year graft and patient survival rates
were 100 per cent in the DHOPE group. Six-month graft survival and 1-year graft and patient survival
rates in the control group were 80, 67 and 85 per cent respectively. During DHOPE, median (i.q.r.)
hepatic adenosine 5′-triphosphate (ATP) content increased 11-fold, from 6 (3–10) to 66 (42–87)𝛍mol
per g protein (P= 0⋅005). All DHOPE-preserved livers showed excellent early function. At 1week after
transplantation peak serum alanine aminotransferase (ALT) and bilirubin levels were twofold lower
in the DHOPE group than in the control group (ALT: median 966 versus 1858units/l respectively,
P=0⋅006; bilirubin: median 1⋅0 (i.q.r. 0⋅7–1⋅4) versus 2⋅6 (0⋅9–5⋅1) mg/dl, P= 0⋅044). None of the ten
DHOPE-preserved livers required retransplantation for non-anastomotic biliary stricture, comparedwith
five of 20 in the control group (P= 0⋅140).
Conclusion: This clinical study of end-ischaemic DHOPE in DCD liver transplantation suggests that the
technique restores hepatic ATP, reduces reperfusion injury, and is safe and feasible. RCTs with larger
numbers of patients are warranted to assess the efficacy in reducing post-transplant biliary complications.
Presented to the 12th Congress of the International Hepato-Pancreato-Biliary Association, São Paulo, Brazil, May
2016, Symposium Experimenteel Onderzoek Heelkundige, Leiden, The Netherlands, December 2015, the 17th
Congress of the European Society for Organ Transplantation, Brussels, Belgium, September 2015, the 21st Annual
International Congress of the International Liver Transplantation Society, Chicago, Illinois, USA, July 2015, the
Fourth European MD/PhD Conference, Groningen, The Netherlands, June 2015, and the 2015 Joint Congress of
the British Transplantation Society and the Dutch Transplant Society, Bournemouth, UK, March 2015; published in
abstract form as Transplantation 2015; 99(Suppl 1): 85–86 and Transpl Int 2015; 28(Suppl S4): 128
[Correction added on 13th April 2017, after first online publication: ‘grafts’ removed from the article title]
Paper accepted 29 January 2017
Published online 10 April 2017 in Wiley Online Library (www.bjs.co.uk). DOI: 10.1002/bjs.10515
Introduction
Donation after circulatory death (DCD) liver grafts are
used increasingly for transplantation in an attempt to
overcome the discrepancy between the number of avail-
able donors and the number of patients waiting for a liver
transplant. A major drawback of DCD livers compared
with donation after brain death (DBD) livers is the
inevitable period of warm ischaemia between withdrawal
of life support and circulatory arrest. This first period of
warm ischaemia and the subsequent cold ischaemia during
transportation lead to depletion of intracellular energy
sources, such as adenosine 5′-triphosphate (ATP), as well as
© 2017 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd. BJS 2017; 104: 907–917
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a  After SCS (back table) b  Start of DHOPE c  After DHOPE
Fig. 1 a–cMacroscopic view of a donor liver during machine perfusion. Liver graft with cannulas in the portal vein and supratruncal
aorta during back-table preparation, and before and after dual hypothermic oxygenated machine perfusion (DHOPE). The asterisk
indicates a wet sterile gauze protecting the arteries. SCS, static cold storage
other metabolic perturbations causing cellular injury and
dysfunction1,2. Graft damage is exacerbated by reperfu-
sion injury, and manifests clinically as an increased risk of
complications and graft failure after transplantation3. The
most frequent complications after DCD liver transplant-
ation are biliary complications4,5, which include a spec-
trum of cholangiopathies causing cholestasis, jaundice
and cholangitis that may lead to graft loss. Non-anasto-
motic biliary stricture (NAS) has been reported in up to
30 per cent of patients following DCD liver transplant-
ation – almost three times higher than in recipients of a
DBD liver3.
Experimental studies6–13 have suggested that machine
preservation may provide better protection of liver grafts
against ischaemia–reperfusion injury than the tradi-
tional method of static cold storage (SCS). Guarrera and
colleagues14,15 were the first to report successful clinical
transplantation of extended criteria DBD donor livers
after ex situ hypothermic machine perfusion (4–6∘C) via
the portal vein and hepatic artery without active oxygena-
tion. Dutkowski and co-workers subsequently reported the
application of hypothermic (10∘C) oxygenated perfusion
in DCD liver transplantation16,17. Although Dutkowski’s
group applied active oxygenation of the perfusion fluid,
they perfused only via the portal vein and not via the hep-
atic artery. It is well known, however, that blood supply to
the bile ducts is largely dependent on the hepatic artery18.
Preservation of the biliary tree is critical, and single por-
tal perfusion may not be sufficient to protect the bile
ducts, especially in DCD liver grafts. Dual hypothermic
oxygenated machine perfusion (DHOPE) combines the
advantages of the two above-mentioned techniques: active
oxygenation and perfusion via both the portal vein and the
hepatic artery19. The hypothesis for the present study was
that DHOPE is feasible and safe in resuscitating DCD
liver grafts.
Methods
Between April 2014 and November 2014, consecutive
patients (aged at least 18 years) undergoing DCD liver
transplantation (Maastricht type 3 and donor bodyweight
above 40 kg) with DHOPE at the authors’ centre were
included in the study. Exclusion criteria for the study
were: inability to give informed consent; high urgency
status; human immunodeficiency virus positivity; pregnant
or nursing; donor positive for hepatitis B or C; or an
expected cold ischaemia time greater than 8 h. All livers
were allocated according to the regular Eurotransplant
rules based on blood type compatibility and Model for
End-stage Liver Disease (MELD) score20. At the time of
listing, patients gave informed consent to the possibility
of receiving a DCD graft. At the time of donor liver offer,
patients gave informed consent for machine preservation
of the donor liver. The study protocol was approved by the
institutional medical ethics committee (METc University
Medical Centre Groningen; record M14.152454) and was
published in an open access registry (www.trialregister.nl;
trial ID NTR4493).
Donor organ procurement and preparation
After circulatory death of the donor and a ‘no-touch’
interval of 5min, aortic flush was performed with at least
4 litres of ice-cold (0–4∘C) Belzer University of Wiscon-
sin (UW®) Cold Storage Solution (UWCSS) (Bridge to
Life, London, UK) to which 50 000 units of heparin was
© 2017 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2017; 104: 907–917
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Fig. 2 Schematic drawing of the set-up of dual hypothermic oxygenated machine perfusion. The liver graft was placed in the reservoir,
which was covered with a transparent lid to maintain a moist and sterile environment. The system was both pressure and temperature
controlled. Two rotary pumps separately provided a pulsatile flow to the hepatic artery (HA) at a mean of 25mmHg (pressure variation
between 20 and 30mmHg) and a continuous flow to the portal vein (PV) at 5mmHg. The perfusion fluid was oxygenated by the
membrane oxygenators, which also regulated the temperature (set to 10∘C). Real-time perfusion flow rates and temperature were
measured by sensors and displayed on both pump units
added. Donors were not heparinized systemically before
circulatory death. A segment of supratruncal aorta was left
attached to the coeliac trunk for later cannulation (Fig. 1).
Bile ducts were flushed with preservation solution and a
further low-pressure portal flush was performed before
packing and transportation in UWCSS. Upon arrival, the
livers were flushed through the portal vein with 1 litre of
ice-cold Belzer MPS® UW Machine Perfusion Solution
(UWMPS) (Bridge to Life).
Dual hypothermic oxygenated machine perfusion
All livers underwent at least 2 h of DHOPE using the Liver
Assist device (Organ Assist, Groningen, TheNetherlands).
Machine perfusion was performed simultaneously with
the recipient hepatectomy. In case of an unexpectedly
difficult hepatectomy, DHOPE was prolonged (in 3
instances by 17, 19 and 52min). The Liver Assist provides
pressure-controlled dual perfusion of the liver with rotary
pumps (Fig. 2). Arterial pressure was set at 25mmHg
resulting in a pulsatile flow (systolic 30mmHg, diastolic
20mmHg) at 60 beats per min. A continuous portal flow
was provided with a pressure of 5mmHg. Pressure settings
were based on previous studies and were subphysiological
to avoid shear stress-induced damage of the endothelium at
low temperatures10,19,21. Four litres of UW MPS, supple-
mented with 3mmol/l glutathione, were used as perfusion
fluid at a temperature of 10∘C. The perfusion fluid was
oxygenated by two hollow-fibre membrane oxygenators
(100 per cent oxygen at 500ml/min), resulting in a partial
pressure of oxygen of at least 450mmHg, as described
previously10,19.
Characteristics of DHOPE such as flow and resistance
were assessed every 10min. Samples of perfusion fluid
were collected every 30min for immediate analysis of
perfusate lactate and glucose using an ABL800 FLEX
analyser (Radiometer, Brønhøj, Denmark). Additional per-
fusate samples were centrifuged for 5min at 2700 r.p.m.
at 4∘C and stored at −80∘C for later biochemical analy-
sis. The concentration of thiobarbituric acid reactive sub-
stances (TBARS) was measured in the perfusion fluid as
a marker of oxidative stress, as described previously10. At
the end of DHOPE, a perfusion fluid sample was col-
lected for microbiological testing. Liver wedge biopsies
© 2017 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2017; 104: 907–917
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Table 1 Donor and recipient characteristics
DHOPE (n=10) Control (n=20) P¶
Donor characteristics
Age (years)* 53 (47–57) 53 (47–58) 0⋅914
Sex ratio (M : F) 5 : 5 13 : 7 0⋅461#
Body mass index (kg/m2)* 23 (20–24) 25 (22–27) 0⋅044
Cause of death 0⋅727#
Trauma 4 6
Postanoxic brain injury 3 5
Cerebrovascular accident 3 9
Other 0 0
Donor highest serum ALT (units/l)* 88 (32–194) 35 (23–99) 0⋅109
Donor risk index*† 1⋅89 (1⋅47–2⋅19) 2⋅00 (1⋅73–2⋅20) 0⋅619
Time from circulatory arrest to cold perfusion (min)* 15 (13–17) 16 (14–18) 0⋅619
Time from withdrawal of life support to cold perfusion (min)* 27 (23–43) 32 (27–39) 0⋅629
Preservation
Duration of DHOPE (min)* 126 (123–135) – -
Total preservation time (min)*‡ 521 (469–592) 503 (476–526) 0⋅448
Recipient characteristics
Age (years)* 57 (54–62) 52 (42–60) 0⋅131
Sex ratio (M : F) 6 : 4 11 : 9 1⋅000#
MELD score*§ 16 (15–22) 22 (17–27) 0⋅109
Indication for liver transplantation 0⋅071#
Alcoholic cirrhosis 3 2
Non-alcoholic steatohepatitis 5 2
Primary sclerosing cholangitis 1 5
Primary and secondary biliary cirrhosis 0 2
Autoimmune hepatitis 0 1
Hepatitis B or C cirrhosis 1 0
Hepatocellular carcinoma 0 4
Cryptogenic cirrhosis 0 3
Familial amyloid neuropathy 0 1
Intraoperative characteristics
Estimated blood loss (litres)* 3⋅6 (1⋅8–4⋅9) 2⋅6 (2⋅1–6⋅6) 0⋅914
Transfusion of red blood cells (units)* 3 (1⋅5–7⋅5) 3 (0⋅3–7⋅5) 0⋅880
Transfusion of FFP (units)* 0 (0–5⋅5) 0 (0–7⋅0) 0⋅914
*Values are median (i.q.r.). †A validated tool for assessing the risk of liver graft failure24; ‡defined as the interval between commencement of aortic cold
flush in the donor and portal reperfusion in the recipient; §defined as the highest laboratory-derived Model for End-stage Liver Disease (MELD) score
or the (non)-standard exception MELD score. DHOPE, dual hypothermic oxygenated machine perfusion; ALT, alanine aminotransferase; FFP, fresh
frozen plasma. ¶Mann–Whitney U test, except #χ2 or Fisher’s exact test.
were taken before and after DHOPE, snap-frozen in
liquid nitrogen and processed for measurement of ATP
concentration22.
Transplantation procedure
Implantations were performed using the piggy-back tech-
nique without use of venovenous bypass. Graft reperfu-
sion was initiated via the portal vein with an in situ flush
of 500ml of recipient’s blood, followed by construction of
the arterial anastomosis, using donor common or proper
hepatic artery. Biliary reconstruction was performed using
duct-to-duct anastomosis without a stent. Immunosup-
pressive therapy consisted of induction with basiliximab
and maintenance immunosuppression with a calcineurin
inhibitor (tacrolimus or ciclosporin) and a rapid taper of
steroids, either with or without mycophenolate mofetil.
Control group
Outcome data were compared with those of a matched
control group. For each recipient of a DHOPE-preserved
graft two control patients were identified within a cohort
of patients who underwent primary DCD liver transplan-
tation between 2008 and 2014 at the authors’ centre.
DCD liver transplantation was initiated at this centre
in 2001, and both procurement and implantation tech-
niques have been standardized in a national protocol, which
has not been changed over time. The DCD livers of
control patients were preserved with conventional SCS
only. Matching criteria were based on known risk factors
for graft survival: recipient age (±5 years), donor warm
ischaemia time (±5min) and MELD score (less than 22 or
at least 23). Donor warm ischaemia time was defined as the
time interval between withdrawal of donor life support and
initiation of aortic cold flush.
© 2017 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2017; 104: 907–917
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a  Graft survival b  Patient survival
Fig. 3 Kaplan–Meier curves of a graft and b patient survival rates within the first year after transplantation in dual hypothermic
oxygenated machine perfusion (DHOPE) and control groups. a P = 0⋅052, b P = 0⋅209 (log rank test)
Post-transplant outcome
The primary endpoint was graft survival at 6months after
transplantation. Graft survival was defined as the time
interval between transplantation and retransplantation
or death from graft failure. Secondary endpoints were
graft and patient survival rates at 1 year, technical safety
of machine perfusion, microbiological testing of perfusion
fluid and postoperative complications. Initial poor func-
tion was defined based on a modification of the Olthoff
criteria: international normalized ratio above 1⋅6 and or a
serum total bilirubin level greater than 10mg/dl on post-
operative day 723. Serum markers of hepatobiliary injury
and function (serum lactate, alanine aminotransferase
(ALT), alkaline phosphatase (ALP), γ-glutamyl trans-
ferase (GGT), prothrombin time and total bilirubin) were
measured using standard biochemical assays.
Other postoperative parameters assessed were duration
of ICU and hospital stay, and postoperative complications,
including biliary complications such as ischaemic cholan-
giopathy, defined as NAS or biliary necrosis. NAS was
defined as bile duct stenosis at any location in the biliary
tree (intrahepatic or extrahepatic, but not at the site of
anastomosis) as detected by endoscopic retrograde or mag-
netic resonance (MRCP) cholangiopancreatography, with
clinical signs of cholestasis and/or cholangitis (including
raised cholestatic laboratory test results such as for serum
GGT and ALP) in the presence of a patent hepatic artery.
Biliary necrosis was defined as evidence of intrahepatic
biloma formation or bile duct leakage. All recipients of a
DHOPE-preserved liver underwentMRCP 6months after
transplantation. All MRCPs were performed in a routine
manner and assessed by an experienced radiologist, who
was not aware of whether a liver had undergone machine
perfusion or not.
Statistical analysis
Continuous variables are presented as median (i.q.r.) and
compared between groups using the Mann–Whitney U
test. Categorical variables are presented as number and
percentage, and compared with the Pearson χ2 test or
Fisher’s exact test. Graft and recipient survival were deter-
mined with the Kaplan–Meier method, and significance of
survival differences was determined with the log rank test.
P < 0⋅050 was considered to indicate statistical signifi-
cance. All statistical analyses were performed using SPSS®
software version 22.0 for Windows® (IBM, Armonk, New
York, USA).
Results
Ten consecutive, unselected DCD liver transplants had
DHOPE preservation before implantation, and no patient
had to be excluded based on the set exclusion criteria.
Twenty control patients were identified from a cohort of
64. Donor and recipient characteristics of patients in the
DHOPE and control groups are summarized in Table 1.
There were no significant differences in baseline charac-
teristics, except for a lower BMI in the DHOPE group.
Graft and patient survival
Six-month and 1-year graft and patient survival rates were
100 per cent (10 of 10) in the DHOPE group, whereas
© 2017 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2017; 104: 907–917
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d  Glucose and lactate
Fig. 4 Characteristics of dual hypothermic oxygenated machine perfusion. a Arterial and portal flow rates were measured by flow
sensors attached to the tubing of the perfusion device. b Perfusion pressure (mmHg) was measured by pressure sensors attached to the
arterial and venous tubing. Vascular resistance was calculated using Ohm’s law and expressed as mmHg per ml per min per kg liver.
c,d Levels of alanine aminotransferase (ALT), glucose and lactate were measured in perfusion fluid samples taken every 30min during
perfusion. Values are median (i.q.r.)
6-month graft survival and 1-year graft and patient survival
rates for the 20 patients in the control group were 80, 67
and 85 per cent respectively (P= 0⋅052 for graft survival,
P= 0⋅209 for patient survival) (Fig. 3). Graft loss in the con-
trol group was due to hepatic artery thrombosis (1 patient),
necrotic bile ducts (2) and NAS (3). Patient death in the
control group was due to angiosarcoma (1 patient), pneu-
monia as a complication of treatment for haemophagocytic
syndrome (1) and haemorrhagic shock due to intrathoracic
bleeding after thoracentesis for pleural effusion (1).
Characteristics of dual hypothermic oxygenated
machine perfusion
No technical problems or device malfunction occurred
during machine perfusion. Microbiological evaluation of
the perfusion fluid revealed no evidence of microbial
contamination. Livers in the DHOPE group were per-
fused for a median duration of 126 (123–135)min after a
median cold ischaemia time of 331 (308–376)min. This
resulted in a total preservation time of 8⋅7 (7⋅8–9⋅9) h
for DHOPE versus 8⋅4 (7⋅9–8⋅8) h in the control group
(P= 0⋅448).
The macroscopic appearance of a representative liver
graft before and after DHOPE is shown in Fig. 1. Flows
increased mainly during the first 30min of DHOPE and
reached a median portal flow of 365ml/min and a median
hepatic arterial flow of 84ml/min after 2 h (Fig. 4a). In
parallel, the vascular resistance decreased during the first
30min and stabilized thereafter (Fig. 4b). ALT concentra-
tion in perfusion fluid increased during the first 30min of
© 2017 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2017; 104: 907–917
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Fig. 5 Post-transplant biochemical markers of hepatic injury and function in dual hypothermic oxygenated machine perfusion
(DHOPE) and control groups: a prothrombin time, b lactate, c alanine aminotransferase (ALT), d total bilirubin, e γ-glutamyl
transferase (GGT), f alkaline phosphatase (ALP). Day 0 was determined as the time interval between reperfusion and midnight. Values
are median (i.q.r.). *P < 0⋅050 (Mann–Whitney U test)
machine perfusion and decreased thereafter, resulting in
a median ALT concentration of 207 (134–878) units/l at
the end of DHOPE (Fig. 4c). Lactate and glucose concen-
trations in the perfusion fluid also increased during the
first 30min and stabilized thereafter (Fig. 4d). There was
no significant increase in the concentration of TBARS in
the perfusion fluid during DHOPE (data not shown).
Hepatic ATP concentration increased significantly dur-
ing DHOPE, from a median of 6 (3–10) to 66 (42–87)
μmol/g (P= 0⋅005). After graft reperfusion in the recipient,
© 2017 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2017; 104: 907–917
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Table 2 Post-transplant outcomes
DHOPE (n=10) Control (n=20) P‡‡
Recovery
Peak serum creatinine at≤1week (mg/day)*† 1⋅4 (1⋅0–2⋅8) 1⋅3 (0⋅8–1⋅8) 0⋅373§§
Duration of ICU stay (days)* 2 (2–6) 2 (1–5) 0⋅475§§
Duration of hospital stay (days)* 22 (16–33) 23 (15–32) 0⋅880§§
Complications
Hypokalaemia (<3⋅5mEq/l) after reperfusion‡ 3 0 0⋅030
Initial poor function§ 0 2 1⋅000
Primary non-function¶ 0 0 –
Relaparotomy# 3 7 1⋅000
Renal failure requiring haemodialysis 1 2 1⋅000
Hepatic artery thrombosis 0 2 0⋅540
Biliary complications
Anastomotic biliary stricture 2** 3†† 1⋅000
Biliary cast formation 3** 3†† 0⋅372
Ischaemic cholangiopathy 1 9 0⋅101
Non-anastomotic biliary stricture 1** 7†† 0⋅210
Massive biliary necrosis 0 2 1⋅000
Retransplantation for biliary complications 0 5 0⋅140
*Values are median (i.q.r.). †SI conversion factor: to convert creatinine to micromoles per litre (μmol/l), multiply by 88⋅4. ‡SI conversion factor: to
convert potassium to millimoles per litre (mmol/l), multiply by 1. §Defined based on a modification of the Olthoff criteria: international normalized ratio
above 1⋅6 and/or serum total bilirubin level greater than 10mg/dl on postoperative day 723. ¶Determined as retransplantation or death within 7 days of
transplantation. #Indications for relaparotomy in dual hypothermic oxygenated machine perfusion (DHOPE) group: intra-abdominal blood loss due to
diffuse oozing (1); removal of surgical gauzes used for packing to control diffuse oozing during transplantation (1); and biliary anastomotic leakage (1).
Indications for relaparotomy in control group: intra-abdominal blood loss due to diffuse oozing (1); removal of surgical gauzes used for packing to control
diffuse oozing during transplantation (4); and biliary anastomotic leakage (2). **One patient had a combination of anastomotic biliary stricture and biliary
cast formation; one patient had biliary cast formation as well as non-anastomotic biliary stricture. ††One patient had non-anastomotic biliary stricture
and later also developed an anastomotic biliary stricture; one patient had biliary cast formation as well as non-anastomotic biliary stricture; two patients
had a combination of non-anastomotic biliary stricture and biliary cast formation. ‡‡χ2 or Fisher’s exact test, except §§Mann–Whitney U test.
hepatic ATP levels were comparable to those at the end of
DHOPE (Fig. S1, supporting information).
Post-transplant hepatobiliary injury and function
Postoperative prothrombin time and serum lactate concen-
trations were comparable in the two groups during the first
7 days after surgery (Fig. 5a,b). Peak serum ALT levels were
significantly lower in recipients of DHOPE-preserved
livers compared with levels in controls (median ALT
966 versus 1858 units/l respectively; P= 0⋅006) (Fig. 5c).
In addition, serum bilirubin concentrations were signifi-
cantly lower on postoperative day 7 in the DHOPE group:
1⋅0 (0⋅7–1⋅4)mg/dl versus 2⋅6 (0⋅9–5⋅1)mg/dl in controls
(P= 0⋅044) (Fig. 5d).
Median serum levels of ALT, GGT, ALP and bilirubin
at 30 days after transplantation were lower in the recip-
ients of DHOPE-preserved livers than in the control
group (ALT: 17 versus 51 units/l respectively, P= 0⋅015;
GGT: 74 versus 176 units/l, P= 0⋅049; ALP: 115 versus
182 units/l, P= 0⋅019; bilirubin: 0⋅5 versus 1⋅0mg/dl,
P= 0⋅019) (Fig.5c–f ). These differences remained signifi-
cant for ALT and ALP even when patients with NAS on
MRCP were excluded from the analyses, suggesting that
DHOPE-preserved livers had less subclinical biliary injury
that was not detected by MRCP, compared with controls.
Post-transplantation outcome
There were no significant differences in kidney func-
tion, length of ICU or hospital stay, or incidence of
postoperative complications, except for postreperfusion
hypokalaemia, which developed in three recipients of a
DHOPE liver (Table 2). One recipient of a DHOPE-
preserved liver developed NAS in segments II and
III of the liver; this was treated successfully with endoscopic
stenting. In contrast, seven of 20 patients in the matched
control group developed NAS; this was treated suc-
cessfully with endoscopic stenting in four patients, but
required retransplantation in three patients. Both patients
in the control group with massive biliary necrosis were
retransplanted.
Discussion
This clinical series of end-ischaemic DHOPE in DCD
liver transplantation suggests that this method of liver
machine preservation is safe and feasible. Compared with
© 2017 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2017; 104: 907–917
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SCS alone, DHOPE seems to provide better preserva-
tion of DCD liver grafts, resulting in a reduction of
ischaemia–reperfusion injury and improved early graft
function. Graft and patient survival rates after transplanta-
tion of DHOPE-preserved DCD livers were 100 per cent
during a 12-month follow-up. One-year graft and patient
survival rates in the matched controls were 67 and 85 per
cent respectively. Although patient survival in the control
group was affected mainly by deaths that were not related
to graft function or biliary complications, survival rates are
consistent with those in recent publications4,25.
Hypothermic machine perfusion is a rapidly develop-
ing and dynamic field with many still unanswered ques-
tions. For example, there is no consensus on the need
for active oxygenation. However, experimental data indi-
cate that one of the main benefits of a short period of
end-ischaemic oxygenated hypothermic perfusion of DCD
livers is the restoration of intrahepatic energy sources.
As a result of the periods of warm and cold ischaemia,
DCD livers become severely ATP depleted. In the present
study, intrahepatic ATP levels increased 11-fold during
DHOPE. This restoration of ATP levels during DHOPE
is remarkable and can be explained only by an effective
extraction and utilization of oxygen from the oxygenated
machine preservation fluid by the mitochondria, despite
low temperatures. However, because of the low tempera-
tures, the subsequent turnover rate of ATP into adenosine
5′-diphosphate by hepatocytes is low, leading to an accu-
mulation of cellular ATP. This finding is very much in line
with data obtained byDutkowski’s group13 in animal exper-
iments, and by the present authors’ group in experimental
studies using discarded human donor livers19,26. Restora-
tion of ATP levels reduces the cellular ‘oxygen debt’,
resulting in reduced production of radical oxygen species
and damage-associated molecular pattern molecules after
warm reperfusion in the recipient6–8. The downstream
effects of this are reduced activation of Kupffer cells and
endothelium, limiting ischaemia–reperfusion injury and
resulting in a downregulation of the immune response after
transplantation11–13. Altogether, these data indicate that
active oxygenation of the perfusion fluid adds significantly
to the benefits of hypothermic machine perfusion.
Another unanswered question is the need for dual ver-
sus single perfusion of livers. It remains unclear whether
dual or single perfusion is equally effective, or whether
one method is superior to the other. A potential risk
of combined portal and arterial perfusion is mechanical
damage that may occur to the hepatic artery, and could
cause a higher incidence of hepatic artery thrombosis fol-
lowing transplantation. For this reason, Dutkowski and
colleagues16,17 used only portal vein perfusion. However,
biliary complications are the main obstacle for wider uti-
lization of DCD livers and, based on the dominant arterial
vasculature of the biliary tree, single-portal perfusion may
not provide optimal preservation of the bile ducts and their
vasculature18. The present authors have avoided manipula-
tion of the hepatic artery by leaving a segment of supra-
truncal aorta attached the donor liver. After machine
perfusion, this part of the arterial vasculature was cut
off and the donor common or proper hepatic artery was
used for anastomosis. None of the patients developed hep-
atic artery thrombosis. Guarrera and co-workers14,15 also
used combined portal and arterial perfusion without an
increased rate of arterial complications.
After transplantation, peak serum ALT levels at
1week were significantly lower in recipients of a
DHOPE-preserved DCD liver than in controls. A high
peak ALT following DCD liver transplantation has been
identified previously as an independent risk factor for the
development of NAS27. Only one patient in the DHOPE
group developed local NAS, limited to the left lateral
segments of the liver, which was treated successfully with
endoscopic stenting. The low incidence of NAS is remark-
able, especially considering the rather long donor warm
ischaemia time (median 27min), reflecting current DCD
practice in the Netherlands3,25. The long donor warm
ischaemia time probably contributes to the high incidence
of NAS of 24–35 per cent in the Netherlands3,25. A
similar high incidence of ischaemic cholangiopathy was
noted in nine of the 20 matched controls, necessitating
retransplantation in five patients. A potentially beneficial
effect of hypothermic oxygenated machine perfusion on
the occurrence of biliary complications after DCD liver
transplantation has also been reported by Dutkowski
et al.16,17. However, when donor warm ischaemia time is
limited, the benefit of hypothermic machine perfusion may
be lower, as short donor warm ischaemia time has been
associated with a low risk of NAS and graft failure28,29.
Formal evidence that hypothermic oxygenated machine
perfusion reduces the incidence of biliary complications
after DCD liver transplantation should come from RCTs.
Based on the present favourable results, a multicentre
RCT comparing end-ischaemic DHOPE with SCS alone
in DCD liver transplantation has been initiated. The pri-
mary endpoint of this study will be NAS within 6months
after transplantation (ClinicalTrials.gov NCT02584283).
Several groups30–32, including that of the authors, have
reported recently on the feasibility and potential benefits
of end-ischaemic normothermic machine perfusion of
human donor livers. In contrast to hypothermic machine
perfusion, normothermic liver perfusion enables an ex situ
functional assessment. This facilitates the identification of
© 2017 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2017; 104: 907–917
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transplantable donor livers that would otherwise have been
declined because of a high risk of primary non-function.
Hypothermic oxygenated machine perfusion does not
allow functional assessment of the liver before transplan-
tation, but rather aims to reduce graft dysfunction and
complications after transplantation. In this respect, the
various types of machine perfusion at different tempera-
tures may prove to be complementary. A major advantage
of hypothermic compared with normothermic machine
perfusion is its relative simplicity and safety. In addition,
hypothermic machine perfusion is associated with lower
costs than normothermic machine perfusion.
Limitations of this study are the sample size and use of
matched historical controls. DCD liver transplantation was
initiated at the authors’ centre in 2001, and both procure-
ment and implantation techniques have been standardized
in a national protocol, which has not been changed over
time. Therefore, no major bias from a learning curve effect
when comparing the DHOPE series (performed in 2014)
with historical controls performed between 2008 and 2014
would be expected. Primary sclerosing cholangitis (PSC)
was the underlying liver disease in five control patients,
compared with one patient in the DHOPE group. In gen-
eral, PSC is not considered a contraindication to DCD
liver transplantation as 30 per cent of donor livers come
from DCD donors and 15–20 per cent of patients requir-
ing a liver transplant in the Netherlands have PSC as the
underlying liver disease. Although patients transplanted
for PSC have a higher risk of developing biliary stric-
ture, only one of the five patients with PSC in the control
group developed NAS. Therefore, this does not explain
the difference in the incidence of NAS between the two
groups.
This small clinical study suggests that end-ischaemic por-
tal and arterial hypothermic oxygenated machine perfu-
sion is feasible and safe in resuscitating DCD liver grafts
before transplantation. DHOPE resulted in restoration of
hepatic ATP content and was associated with a reduc-
tion in ischaemia–reperfusion injury, as well as better
hepatobiliary function after transplantation. However, the
efficacy of DHOPE in reducing (biliary) complications
after transplantation remains to be determined in an RCT
before the technology is implemented routinely in DCD
liver transplantation.
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